Reklama
twitter
youtube
facebook
instagram
linkedin
Reklama
Reklama

Sopharma AD: SA-RS 2020 - wersja angielska (2021-04-28)

|
selectedselectedselected
Reklama
Aa
Udostępnij
facebook
twitter
linkedin
wykop

UNI-EN 14:Audited Consolidated Financial Statements of Sopharma Group for 2020

Firma: SOPHARMA AD
Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. SFA_Audited_Consolidated_Financial_Statements_2020.rar Audited Consolidated Financial Statements of Sopharma Group for 2020

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 14 / 2020
Date of issue: 2021-04-28
Short name of the issuer
SOPHARMA AD
Subject
Audited Consolidated Financial Statements of Sopharma Group for 2020
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Consolidated Audited Financial Report according to IFRS as at 31 December 2020
Notes to the Consolidated Audited financial report as at 31 December 2020
Consolidated Management report as at 31 December 2020
Consolidated Audited Financial Report according to BFSC standards as at 31 December 2020
Auditor's declaration as at 31 December 2020
Auditor's report as at 31 December 2020
Consolidated Corporate Governance Declaration as at 31 December 2020
Declaration by responsible directors as at 31 December 2020
Consolidated Non-financial Declaration to the Annual Financial Report as at 31 December 2020
Annexes
File Description
SFA_Audited_Consolidated_Financial_Statements_2020.rar
SFA_Audited_Consolidated_Financial_Statements_2020.rar
Audited Consolidated Financial Statements of Sopharma Group for 2020

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2021-04-28 Ognian Ivanov Donev Executive Director

Cena akcji Sopharma

Cena akcji Sopharma w momencie publikacji komunikatu to 8.0 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.

W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.

Jesteś dziennikarzem i szukasz pracy? Napisz do nas

Masz lekkie pióro? Interesujesz się gospodarką i finansami? Możliwe, że szukamy właśnie Ciebie.

Zgłoś swoją kandydaturę

Reklama